We Think Ouro Fino Saúde Animal Participações' (BVMF:OFSA3) Healthy Earnings Might Be Conservative
Investors signalled that they were pleased with Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) most recent earnings report. Looking deeper at the numbers, we found several encouraging factors beyond the headline profit numbers.
See our latest analysis for Ouro Fino Saúde Animal Participações
The Impact Of Unusual Items On Profit
To properly understand Ouro Fino Saúde Animal Participações' profit results, we need to consider the R$22m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If Ouro Fino Saúde Animal Participações doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Ouro Fino Saúde Animal Participações' Profit Performance
Unusual items (expenses) detracted from Ouro Fino Saúde Animal Participações' earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Ouro Fino Saúde Animal Participações' statutory profit actually understates its earnings potential! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. In terms of investment risks, we've identified 1 warning sign with Ouro Fino Saúde Animal Participações, and understanding it should be part of your investment process.
This note has only looked at a single factor that sheds light on the nature of Ouro Fino Saúde Animal Participações' profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:OFSA3
Ouro Fino Saúde Animal Participações
Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.
Excellent balance sheet and slightly overvalued.